UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrant    Filed by a Party other than the Registrant  

Check the appropriate box:

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to §240.14a-12

 

 

Quest Diagnostics Incorporated

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

 

1)    Title of each class of securities to which transaction applies:

 

2)    Aggregate number of securities to which transaction applies:

 

 

3)    Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

4)    Proposed maximum aggregate value of transaction:

 

5)    Total fee paid:

 

 

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 


 

1)    Amount Previously Paid:

 

2)    Form, Schedule or Registration Statement No.:

 

3)    Filing Party:

 

4)    Date Filed:

 

 

                

The Compensation Committee of our Board of Directors has approved an amendment to the terms of the Amended and Restated Employee Long-Term Incentive Plan (the "Plan"), which is being submitted to our shareholders at the 2005 annual meeting of shareholders of Quest Diagnostics Incorporated to be held on Tuesday, May 10, 2005.  The proposed amendment will limit to 3,500,000 the maximum number of shares that may be delivered in connection with awards of restricted stock and other stock-based awards under the Plan that are not stock options or stock appreciation rights on or after the date the Plan is approved by shareholders. This filing amends the filing made previously today.